First randomized controlled trial shows promise of a ketogenic diet in psychotic disorders

First randomized controlled trial shows promise of a ketogenic diet in psychotic disorders. Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar 1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared with diet-as-usual during an initial one-month RCT open-label phase.

• Ponto de atenção: first.
• Ponto de atenção: randomized.
• Ponto de atenção: controlled.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.